Incyte Announces U.S. Food and Drug Administration Grants Priority Review for Axatilimab for the Treatment of Chronic Graft-Versus-Host Disease

- Priority Review acceptance based on positive results of AGAVE-201 study

...

Related Keywords

Delaware ,United States ,American , ,American Association Of Hematology Annual Meeting ,Syndax Pharmaceuticals Nasdaq ,Exchange Commission ,American Society Of Hematology Annual Meeting ,Drug Administration ,Priority Review ,Biologics License Application ,Prescription Drug User Fee Act ,Plenary Scientific Session ,American Society ,Hematology Annual Meeting ,Syndax Pharmaceuticals ,Chief Executive Officer ,American Association ,Orphan Drug Designation ,Modified Lee Symptom ,Immunology Insights ,Real World Treatment ,